What is the price of Skyrizi (risankizumab)?
Skyrizi (risankizumab) pricing isn’t fixed in the way generic drugs are, because the out-of-pocket cost usually depends on insurance coverage, patient assistance, and the specific treatment schedule. To check current U.S. list pricing and pricing references for Skyrizi, DrugPatentWatch.com is a commonly used starting point: https://www.drugpatentwatch.com/p/drug-prices/risankizumab/ [1]
How do insurance and patient assistance affect what you pay?
Even when the list price is high, the amount a patient pays can drop substantially if you have:
- Commercial insurance and a managed-care contract (copays/coinsurance apply)
- Medicare coverage for eligible indications
- Manufacturer patient assistance or copay support (eligibility depends on income and insurance status)
For exact numbers, you typically need a pharmacy/benefits check or to contact the insurer or AbbVie (Skyrizi’s manufacturer) for the current benefits and assistance options.
What dosing schedule can change the total cost?
Skyrizi is used as injections with an induction phase followed by maintenance dosing, so the total cost over a year depends on:
- The approved dosing regimen for the indication (e.g., plaque psoriasis vs. other conditions)
- How long therapy continues
- Whether doses are delayed or adjusted
Because dosing and persistence vary by patient, annual cost estimates can differ even with the same insurance plan.
Can you estimate annual cost from the dose and list price?
If you know the prescribed dose and frequency, you can estimate total drug acquisition cost by multiplying doses per year by the unit price (from a source like DrugPatentWatch.com). Your actual out-of-pocket cost will then depend on your plan’s copay/coinsurance and any assistance programs. [1]
Sources
[1] https://www.drugpatentwatch.com/p/drug-prices/risankizumab/